Characterizing Frailty in Older Adults with Sickle Cell Disease Using a Sickle Cell Frailty Index (FI-SCD)
使用镰状细胞衰弱指数 (FI-SCD) 描述患有镰状细胞病的老年人的衰弱特征
基本信息
- 批准号:10302376
- 负责人:
- 金额:$ 16.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-15 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAdultAgeAgingAmericanAnemiaBiomedical ResearchBody Weight decreasedCaringCessation of lifeChronologyClinicalClinical InvestigatorComputerized Medical RecordCoupledCross-Sectional StudiesDataDependenceDeteriorationDevelopmentElderlyEnrollmentFailureGait speedGenotypeGeriatric AssessmentGeriatricsGoalsHealthHealth StatusHemolysisHospitalizationImpaired cognitionImpairmentIndividualInterventionKnowledgeLaboratoriesLeadLife Cycle StagesLife ExpectancyLiteratureMeasuresMentorshipMethodsMissionModificationNational Institute on AgingOrganPainPain intensityPain interferenceParticipantPatientsPersonal SatisfactionPhenotypePhysical activityPhysiologicalPilot ProjectsPopulationPulmonary Heart DiseaseROC CurveResearchResearch PersonnelRiskRisk FactorsSamplingSensitivity and SpecificitySensorySickle CellSickle Cell AnemiaSumSyndromeTraining ProgramsWorkadverse outcomeaging populationbasebody systemcareercohortcomorbiditydisabilitydisability riskexercise trainingexhaustionexperiencefrailtyfunctional declinehigh riskimprovedimproved functioningindexinglow socioeconomic statusmortalitymortality riskmultidisciplinarypopulation stratificationprematurepreservationpreventprospectiverisk stratificationsocioeconomicsstressorsuccess
项目摘要
Individuals with sickle cell disease (SCD) are living longer than ever before. As the number of
older adults living with SCD grows, there is a greater need for data to determine the appropriate
care for this population. As individuals with SCD age, they demonstrate substantial and early
deterioration of multiple organ systems, which causes complications often seen in geriatric
populations, such as cardiopulmonary disease, sensory impairment, functional decline, and
cognitive impairment. Failure to recognize vulnerabilities and functional decline can lead to
disability, dependence in activities of daily living, and premature death. Frailty is a syndrome
characterized by decreased physiologic reserve and increased vulnerability to stressors that lead
to adverse outcomes. Individuals with SCD experience a variety of stressors, such as
hospitalizations for vasooclussive pain crises and organ damage; however, frailty has never been
defined in people with SCD. The long-term objective of this research is to understand frailty,
accelerated aging, functional decline in older adults with SCD and develop interventions to
ameliorate these issues. The purpose of this study is to characterize frailty in older adults with
SCD using a laboratory-based Sickle Cell Disease Frailty Index (FI-SCD) and a validated
measure of frailty, the Fried Frailty Phenotype (FP). To achieve these goals, the investigators
will determine the relationship between FI-SCD and FP in a single-center cross-sectional study
of 100 older adults with SCD (defined as age 40 and older). For the first aim, the investigators
developed a frailty index using routine laboratory variables associated with chronological aging
and mortality in SCD and geriatrics. A frailty index score will be calculated by taking the sum of
heath deficits and dividing that by the total number of variables evaluated. The investigators will
compare the FI-SCD to FP, using correlation coefficient and ROC curves to describe sensitivity
and specificity of FI-SCD for FP. For the second aim, investigators will identify factors associated
with frailty in older adults with SCD by comparing frailty scores to PROMIS Pain Intensity,
PROMIS Pain Interference, SCD genotype, SCD-complications, and non-SCD comorbidities.
Factors associated with FI-SCD and FP will be identified using canonical correlation. Developing
a frailty index for older adults with SCD will provide a method for early risk stratification of this
population and will create a framework for developing interventions to prevent frailty, improve
function, and reduce mortality. This research is consistent with the National Institute of Aging’s
mission of improving the health and well-being of older Americans through biomedical research.
镰状细胞病(SCD)患者的寿命比以往任何时候都长。随着......的数量的......
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARITY IBILOLA OYEDEJI其他文献
CHARITY IBILOLA OYEDEJI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARITY IBILOLA OYEDEJI', 18)}}的其他基金
Sickle Cell Disease Functional Assessment Validation and Exercise Pilot Intervention
镰状细胞病功能评估验证和运动试点干预
- 批准号:
10570743 - 财政年份:2023
- 资助金额:
$ 16.1万 - 项目类别:
Characterizing Frailty in Older Adults with Sickle Cell Disease Using a Sickle Cell Frailty Index (FI-SCD)
使用镰状细胞衰弱指数 (FI-SCD) 描述患有镰状细胞病的老年人的衰弱特征
- 批准号:
10466983 - 财政年份:2021
- 资助金额:
$ 16.1万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 16.1万 - 项目类别:
Research Grant